CompletedNCT03107026
A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating disorders
Researchers compared dasotraline 4mg, dasotraline 6mg and placebo, tracking side effects to assess safety and tolerability in adults with binge eating.
Medication studyAges 18–55United States
Understand this study
What did researchers investigate?
Researchers compared dasotraline 4mg, dasotraline 6mg and placebo, tracking side effects to assess safety and tolerability in adults with binge eating.
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- Phoenix and 49 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: March 31, 2017
- Recruitment status
- Completed
- Enrollment listed in the registry
- 491
- Sponsor
- Sumitomo Pharma America, Inc.
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT03107026
- Official title
Show the full official title
A 12-week, Randomized, Double-blind, Parallel-group, Placebo-controlled, Fixed-dosed, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Dasotraline in Adults With Moderate to Severe Binge Eating Disorder
Get this study by email
Recruitment & locations
CompletedPhoenix · Beverly Hills · Encino
44 more locations
- Garden Grove
- Newport Beach
- San Diego
- San Marcos
- Santa Ana
- Colorado Springs
- Denver
- Cromwell
- Fort Myers
- Jacksonville
- South Miami
- Atlanta
- Marietta
- Libertyville
- Prairie Village
- Wichita
- Belmont
- Boston
- Methuen
- Watertown
- Rochester Hills
- Saint Charles
- Portsmouth
- Cherry Hill
- Mount Kisco
- New York
- Raleigh
- Akron
- Cincinnati
- Dayton
- Mason
- Portland
- Salem
- Allentown
- Greer
- Mt. Pleasant
- Memphis
- Nashville
- Austin
- Houston
- Richardson
- San Antonio
- Murray
- Woodstock
Questions about this study
What did researchers investigate?
Researchers compared dasotraline 4mg, dasotraline 6mg and placebo, tracking side effects to assess safety and tolerability in adults with binge eating.
Who is behind this study?
The study sponsor is Sumitomo Pharma America, Inc., a pharmaceutical company.
Did this study involve medication?
Yes. The study involved medication, including dasotraline 4mg, dasotraline 6mg and Placebo.
Who was this study for?
Listed age limits: 18 years to 55 years.
